αž‘αžΈαž•αŸ’αžŸαžΆαžš
Teva Pharmaceutical Industries Ltd
13.50€
αž—αžΆαž‚β€‹αž αŸŠαž»αž“αž˜αžΌαž›αž”αžαŸ’αžšαžŠαŸ‚αž›αž”αžΆαž“αž…αž»αŸ‡αž”αž‰αŸ’αž‡αžΈαž“αŸ… DE
αž”αž·αž‘αž–αžΈαž˜αž»αž“
14.00€
αž…αž“αŸ’αž›αŸ„αŸ‡αžαŸ’αž„αŸƒαž“αŸαŸ‡
13.50€ - 14.05€
αž…αž“αŸ’αž›αŸ„αŸ‡αž˜αž½αž™αž†αŸ’αž“αžΆαŸ†αž…αž»αž„αž€αŸ’αžšαŸ„αž™
11.50€ - 21.90€
αžŠαžΎαž˜β€‹αž‘αž»αž“β€‹αž‘αžΈαž•αŸ’αžŸαžΆαžš
16.69Β αž”αŸŠαžΈαž›αžΆαž“ USD
αž‘αŸ†αž αŸ†αž‡αž½αž‰αžŠαžΌαžšαž˜αž’αŸ’αž™αž˜
3.44αž–αžΆαž“αŸ‹
αž’αž“αž»αž”αžΆαž P/E
-
αž‘αž·αž“αŸ’αž“αž•αž›β€‹αž—αžΆαž‚αž›αžΆαž—
-
αž€αŸ’αž“αž»αž„β€‹αž–αŸαžαŸŒαž˜αžΆαž“β€‹
αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αžšαž”αžΆαž™αž€αžΆαžšαžŽαŸαž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
(USD)αž’αŸ’αž“αžΌ 2024αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›
4.23Β αž”αŸŠαžΈαž›αžΆαž“-5.12%
αž…αŸ†αžŽαžΆαž™αž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
1.23Β αž”αŸŠαžΈαž›αžΆαž“5.32%
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
-217.00Β αž›αžΆαž“-146.87%
αž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαŸαž‰αžŸαž»αž‘αŸ’αž’
-5.13-149.37%
β€‹αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’β€‹αž€αŸ’αž“αž»αž„αž˜αž½αž™αž—αžΆαž‚αž αŸŠαž»αž“
0.71-29.00%
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’αž˜αž»αž“αž€αžΆαžšαž”αŸ’αžšαžΆαž€αŸ‹ αž–αž“αŸ’αž’ αž€αžΆαžšαžšαŸ†αž›αžŸαŸ‹ αž“αž·αž„αž€αžΆαžšαž€αžΆαžαŸ‹αžšαŸ†αž›αžŸαŸ‹
1.16Β αž”αŸŠαžΈαž›αžΆαž“-23.40%
αž’αžαŸ’αžšαžΆαž–αž“αŸ’αž’αžŠαŸ‚αž›αž˜αžΆαž“αž”αŸ’αžšαžŸαž·αž‘αŸ’αž’αž—αžΆαž–
-11.34%β€”
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
(USD)αž’αŸ’αž“αžΌ 2024αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹ αž“αž·αž„αž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚αžšαž™αŸˆαž–αŸαž›αžαŸ’αž›αžΈ
3.30Β αž”αŸŠαžΈαž›αžΆαž“2.29%
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
39.33Β αž”αŸŠαžΈαž›αžΆαž“-9.55%
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
33.61Β αž”αŸŠαžΈαž›αžΆαž“-4.94%
αž˜αžΌαž›β€‹αž’αž“αžŸαžšαž»αž”
5.72Β αž”αŸŠαžΈαž›αžΆαž“β€”
αž—αžΆαž‚αž αŸŠαž»αž“β€‹αž˜αž·αž“β€‹αž‘αžΆαž“αŸ‹αž”αžΆαž“αž”αž„αŸ‹
1.13Β αž”αŸŠαžΈαž›αžΆαž“β€”
αžαž˜αŸ’αž›αŸƒαž’αŸ€αž”αž“αžΉαž„αžŸαŸ€αžœαž—αŸ…
2.95β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαž‘αŸ’αžšαž–αŸ’αž™
5.51%β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαžŠαžΎαž˜αž‘αž»αž“
9.01%β€”
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
(USD)αž’αŸ’αž“αžΌ 2024αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
-217.00Β αž›αžΆαž“-146.87%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
575.00Β αž›αžΆαž“-51.44%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚
202.00Β αž›αžΆαž“-32.89%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž αž·αžšαž‰αŸ’αž‰β€‹αž”αŸ’αž”αž‘αžΆαž“
-674.00Β αž›αžΆαž“-17.01%
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
-19.00Β αž›αžΆαž“-101.94%
αž›αŸ†αž αžΌαžšαžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž‘αŸ†αž“αŸαžš
-13.25Β αž›αžΆαž“-101.08%
αž’αŸ†αž–αžΈ
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
αž”αžΆαž“αž”αž„αŸ’αž€αžΎαžαž‘αžΎαž„
13 αž€αž»αž˜αŸ’αž—αŸˆ 1944
αžαŸ†αž”αž“αŸ‹β€‹αž”αžŽαŸ’αžŠαžΆαž‰
αž”αž»αž‚αŸ’αž‚αž›αž·αž€
34,789
αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αž…αŸ’αžšαžΎαž“αž‘αŸ€αž
αž’αŸ’αž“αž€αž’αžΆαž…αž…αžΆαž”αŸ‹αž’αžΆαžšαž˜αŸ’αž˜αžŽαŸαž›αžΎ
αž”αž‰αŸ’αž‡αžΈαž“αŸαŸ‡αžαŸ’αžšαžΌαžœαž”αžΆαž“αž”αž„αŸ’αž€αžΎαžαž‘αžΎαž„αž–αžΈαž€αžΆαžšαžŸαŸ’αžœαŸ‚αž„αžšαž€αžαŸ’αž˜αžΈαŸ— αž˜αžΌαž›αž”αžαŸ’αžšαžŠαŸ‚αž›αž”αžΆαž“αžαžΆαž˜αžŠαžΆαž“ αž“αž·αž„αžŸαž€αž˜αŸ’αž˜αž—αžΆαž–αž•αŸ’αžŸαŸαž„αž‘αŸ€αžαŸ” αžŸαŸ’αžœαŸ‚αž„αž™αž›αŸ‹αž”αž“αŸ’αžαŸ‚αž˜

αž‘αž·αž“αŸ’αž“αž“αŸαž™ αž“αž·αž„αž–αŸαžαŸŒαž˜αžΆαž“αž‘αžΆαŸ†αž„αž’αžŸαŸ‹αžαŸ’αžšαžΌαžœαž”αžΆαž“αž•αŸ’αžαž›αŸ‹αž‡αžΌαž“ β€œαžŠαžΌαž…αžŠαŸ‚αž›αž˜αžΆαž“β€ αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αžαŸ‚αž‚αŸ„αž›αž”αŸ†αžŽαž„αž–αŸαžαŸŒαž˜αžΆαž“αž•αŸ’αž‘αžΆαž›αŸ‹αžαŸ’αž›αž½αž“αž”αŸ‰αž»αžŽαŸ’αžŽαŸ„αŸ‡ αž αžΎαž™αž˜αž·αž“αž˜αžΆαž“αž‚αŸ„αž›αž”αŸ†αžŽαž„αž•αŸ’αžŠαž›αŸ‹β€‹αž‡αžΆαžŠαŸ†αž”αžΌαž“αŸ’αž˜αžΆαž“αž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž» αž¬αž€αŸαžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž‚αŸ„αž›αž”αŸ†αžŽαž„αž–αžΆαžŽαž·αž‡αŸ’αž‡αž€αž˜αŸ’αž˜αž¬αž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚ αž–αž“αŸ’αž’ αž…αŸ’αž”αžΆαž”αŸ‹ αž‚αžŽαž“αŸαž™αŸ’αž™ αž¬αžŠαŸ†αž”αžΌαž“αŸ’αž˜αžΆαž“αž•αŸ’αžŸαŸαž„αž‘αŸ€αžαž‘αžΎαž™αŸ” Google αž˜αž·αž“αž˜αŸ‚αž“αž‡αžΆαž‘αžΈαž”αŸ’αžšαžΉαž€αŸ’αžŸαžΆαž•αŸ’αž“αŸ‚αž€αžœαž·αž“αž·αž™αŸ„αž‚ αž¬αž‘αžΈαž”αŸ’αžšαžΉαž€αŸ’αžŸαžΆαž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»αž‘αŸ αž“αž·αž„αž˜αž·αž“αž”αž‰αŸ’αž…αŸαž‰αž‘αžŸαŸ’αžŸαž“αŸˆ αž€αžΆαžšαžŽαŸ‚αž“αžΆαŸ† αž¬αž‚αŸ†αž“αž·αžαž™αŸ„αž”αž›αŸ‹αž–αžΆαž€αŸ‹αž–αŸαž“αŸ’αž’αž“αžΉαž„αž€αŸ’αžšαž»αž˜αž αŸŠαž»αž“αžŽαžΆαž˜αž½αž™αžŠαŸ‚αž›αž˜αžΆαž“αž€αŸ’αž“αž»αž„αž”αž‰αŸ’αž‡αžΈαž“αŸαŸ‡ αž¬αž˜αžΌαž›αž”αžαŸ’αžšαžŽαžΆαž˜αž½αž™αžŠαŸ‚αž›αž…αŸαž‰αžŠαŸ„αž™αž€αŸ’αžšαž»αž˜αž αŸŠαž»αž“αž‘αžΆαŸ†αž„αž“αŸ„αŸ‡αžŠαŸ‚αžšαŸ” αžŸαžΌαž˜αž–αž·αž‚αŸ’αžšαŸ„αŸ‡αž‡αžΆαž˜αž½αž™αžˆαŸ’αž˜αž½αž‰αž€αžŽαŸ’αžαžΆαž› αž¬αžαŸ†αžŽαžΆαž„αž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»αžšαž”αžŸαŸ‹αž’αŸ’αž“αž€ αžŠαžΎαž˜αŸ’αž”αžΈαž•αŸ’αž‘αŸ€αž„αž•αŸ’αž‘αžΆαžαŸ‹αžαž˜αŸ’αž›αŸƒαž˜αž»αž“αž“αžΉαž„αž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžšαž‡αž½αž‰αžŠαžΌαžšαžŽαžΆαž˜αž½αž™αŸ” αžŸαŸ’αžœαŸ‚αž„αž™αž›αŸ‹αž”αž“αŸ’αžαŸ‚αž˜
αž€αŸαž˜αžΆαž“β€‹αž’αŸ’αž“αž€β€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αžŠαŸ‚αžš
αžŸαŸ’αžœαŸ‚αž„αžšαž€
αžŸαž˜αŸ’αž’αžΆαžβ€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž”αž·αž‘β€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž€αž˜αŸ’αž˜αžœαž·αž’αžΈ Google
αž˜αŸ‰αžΊαž“αž»αž™αžŠαžΎαž˜